Impact of thoracic radiotherapy on first‐line treatment outcomes in ES‐SCLC patients

Impact of thoracic radiotherapy on first‐line treatment outcomes in ES‐SCLC patients

Abstract Background The therapeutic advantage of thoracic radiotherapy (tRT) as an adjunct to first‐line immunotherapy and chemotherapy in patients with extensive‐stage small cell lung cancer (ES‐SCLC) remains unclear. We sought to elucidate this in a retrospective cohort study comparing the effecti...

Descripció completa

Dades bibliogràfiques
Autors principals:	Xiaoli Mu, Yixin Zhou, Qing Liu, Jiantao Wang, Feng Xu, Feng Luo, Ke Wang, Lu Li, Panwen Tian, Yalun Li, Jiewei Liu, Yan Zhang, Jiyan Liu, Yan Li
Format:	Article
Idioma:	English
Publicat:	Wiley 2024-09-01
Col·lecció:	Cancer Medicine
Matèries:	Chemotherapy Extensive‐stage small cell lung cancer Immunotherapy Survival outcomes Thoracic radiotherapy
Accés en línia:	https://doi.org/10.1002/cam4.70175

Ítems similars

Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC
per: Gustav Graabak, MD, et al.
Publicat: (2024-09-01)

Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis
per: Yueyuan Yao, et al.
Publicat: (2024-02-01)

Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer
per: Jianfeng Peng, et al.
Publicat: (2023-07-01)

Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive‐stage small cell lung cancer (ES‐SCLC): Study protocol
per: Lei Deng, et al.
Publicat: (2024-04-01)

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
per: Huanhuan Li, et al.
Publicat: (2023-08-01)

Relationship Between Heart Irradiation Dose-volume and Radiation-induced Cardiac Toxicity in Radiotherapy for Thoracic Neoplasms
per: LI Huan, et al.
Publicat: (2018-11-01)

Combined SCLC clinical and pathological aspects
per: Filiz Çimen, et al.
Publicat: (2022-06-01)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
per: Yongbo Xiang, et al.
Publicat: (2023-07-01)

Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
per: Arani Sathiyapalan, et al.
Publicat: (2022-11-01)

Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trialResearch in context
per: Dawei Chen, et al.
Publicat: (2024-09-01)

Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
per: Bingwen Zou, et al.
Publicat: (2020-03-01)

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada
per: Anifat A. Elegbede, MSc, MbChB, et al.
Publicat: (2021-12-01)

Single institution experience of MRI-guided radiotherapy for thoracic tumors and clinical characteristics impacting treatment duty cycle
per: Joseph A. Miccio, et al.
Publicat: (2024-06-01)

Innovative regression model-based decision support tool for optimizing radiotherapy techniques in thoracic esophageal cancer
per: Yuxing Li, et al.
Publicat: (2024-07-01)

Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer
per: Yu Chen, et al.
Publicat: (2021-12-01)

Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma
per: Xiaofei Zhang, et al.
Publicat: (2018-12-01)

The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy
per: Feihu Chen, et al.
Publicat: (2024-05-01)

Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs
per: Mu F, et al.
Publicat: (2023-04-01)

Fertility impairment in radiotherapy
per: Marta Biedka, et al.
Publicat: (2016-02-01)

A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy
per: Wenjie Tang, et al.
Publicat: (2021-05-01)

Role of metformin in radiotherapy and chemotherapy
per: Yasemin Benderli Cihan
Publicat: (2019-03-01)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
per: Liming Xu, et al.
Publicat: (2023-09-01)

The role of radiotherapy in extensive-stage small cell lung cancer: insights from treatment failure patterns in the era of immunotherapy
per: Ya Zhang, et al.
Publicat: (2024-12-01)

Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy
per: Wenxiao Jia, et al.
Publicat: (2021-02-01)

Different Radiotherapy Methods: A Review
per: Gholamhasan Haddadi, et al.
Publicat: (2013-03-01)

The effects of radiotherapy and chemotherapy on oral tissues
per: Petrović Milica S., et al.
Publicat: (2019-01-01)

Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review
per: Tongzhen Xu, et al.
Publicat: (2022-11-01)

A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene‐negative metastatic non‐small cell lung cancer
per: Yanan Wang, et al.
Publicat: (2024-03-01)

Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial
per: Farastuk Bozorgmehr, et al.
Publicat: (2022-09-01)

Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis
per: Qi J, et al.
Publicat: (2019-12-01)

Evolution of radiotherapy and chemotherapy practice in malignant gliomas
per: Anusheel Munshi, et al.
Publicat: (2013-05-01)

Clinical outcomes and synergistic effect between radiotherapy and immunotherapy in patients with extensive-stage small cell lung cancer: a real-world study
per: Meiling Sun, et al.
Publicat: (2024-09-01)

Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer
per: K. Haslett, et al.
Publicat: (2021-05-01)

Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
per: Malene Støchkel Frank, et al.
Publicat: (2018-01-01)

Assessment of short-term effects of thoracic radiotherapy on the cardiovascular parasympathetic and sympathetic nervous systems
per: Shuang Wu, et al.
Publicat: (2023-09-01)

Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review
per: Tongzhen Xu, et al.
Publicat: (2023-04-01)

Case Report: Grade 4 pneumonitis occurred after thoracic radiotherapy and dacomitinib in a patient with lung adenocarcinoma
per: Ailing Liu, et al.
Publicat: (2025-02-01)

Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review
per: Butuo Li, et al.
Publicat: (2021-03-01)

Mediastinal radiotherapy after adjuvant chemotherapy for resected non–small cell lung cancer with N2 lymphadenopathy: A novel meta-analysisCentral MessagePerspective
per: Leanne Harling, PhD, FRCS, et al.
Publicat: (2021-03-01)

Research progress on animal models of oral mucositis caused by radiotherapy and chemotherapy
per: ZOU Xiaolong, et al.
Publicat: (2020-05-01)